A Clinical Study of Injectable IMM0306 in Combination With Lenalidomide

Clinical trial NCT05771883 · UNKNOWN

Trial details

NCT number: NCT05771883
Sponsor: ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

B-cell Non-Hodgkin's Lymphoma

Start date: 2023-05-01
Primary completion: 2025-05-01
Enrollment: 102

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.